OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 66 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 4.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $236,000 | -82.4% | 549,500 | -76.9% | 0.00% | -100.0% |
| Q1 2016 | $1,340,000 | -55.9% | 2,381,100 | +34.8% | 0.00% | -57.1% |
| Q4 2015 | $3,038,000 | -48.2% | 1,766,200 | -36.5% | 0.01% | -50.0% |
| Q3 2015 | $5,867,000 | +181.9% | 2,780,376 | +561.4% | 0.01% | +180.0% |
| Q2 2015 | $2,081,000 | – | 420,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 5,427,559 | $2,334,000 | 1.60% |
| Scale Management, LLC | 1,312,575 | $564,000 | 1.34% |
| Foresite Capital Management III, LLC | 2,542,575 | $1,093,000 | 0.75% |
| BVF INC/IL | 5,252,100 | $2,258,000 | 0.48% |
| TIVERTON ASSET MANAGEMENT LLC | 45,313 | $4,261,000 | 0.18% |
| Baupost Group | 22,268,399 | $9,575,000 | 0.13% |
| Rhenman & Partners Asset Management AB | 1,200,000 | $516,000 | 0.09% |
| NEA Management Company, LLC | 370,900 | $1,595,000 | 0.08% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $2,649,000 | 0.06% |
| Palo Alto Investors LP | 1,673,024 | $719,000 | 0.05% |